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Genomic Structure, Chromosomal Localization, and Conserved Alternative Splice Forms of Thrombopoietin
By Austin L. Gurney, Wun-Jing Kuang, Ming-Hong Xie, Beth E. Malloy, Dan L. Eaton, and Frederic J. de Sauvage Thrombopoietin (TPO), the ligand for c-mpl, is a novel cytokine comprising an amino terminal domain with homology to erythropoietin and a glycosylated carboxyl terminal domain that does not bear overall homology to other known proteins. We report the cloning of cDNAs encoding the porcine and murine TPO and the characterization of the human TPO gene. The cDNA for an additional splice form (TPO-2) with a four-amino-acid deletion within the erythropoietinlike domain has been isolated and is conserved between HE ONCOGENE c-mpl is a member of the hematopoietic receptor family. It was identified as the cellular homolog of the viral oncogene v-mpl present in the rnyeloproliferative leukemia virus (MPLV).' The receptor bears homology to other members of the hematopoietin receptor superfamily, including the erythropoietin (epo) and interleukin-3 (IL-3) receptors.* Expression of c-mpl mRNA in mice is restricted to fetal liver, spleen, and bone marrow, suggesting a role in hematopoie~is.~ Further analysis of human adult tissues has shown that c-mpl mRNA is present in hematopoietic progenitors, megakaryocytes, and platelets, but not other hematopoietic cell lineage^.^ Antisense oligodeoxynucleotides of c-mpl selectively inhibited in vitro rnegakaryocytic colony formation without affecting the growth of erythroid or granulomacrophage colonies! Collectively, these observations suggest that c-mpl and its putative ligand might function in regulating megakaryocytopoiesis.
Recently, the c-mpl ligand thrombopoietin (TPO) was purified and cloned from several specie^.^" The human TPO cDNA sequence predicts a mature protein of 332 amino acids that can be divided into two domains: an amino terminal half of 153 amino acids with homology to erythropoietin and a unique C-terminal domain of 179 amino acids containing multiple potential N-linked glycosylation sites. Both recombinant full-length human TPO and a truncated form consisting of the epo-like domain (TPOIs3) stimulated [3H]-thymidine incorporation in murine Ba/F3 cells transfected with human c-mpl, demonstrating that the epo-like domain alone is sufficient for activation of c-mpl.' Recombinant human TPO stimulated human megakaryocytopoiesis in vitro alone or in the presence of other exogenously added early-acting hematopoietic growth factor^.^,^.^ Also, TPO stimulated platelet production in mice and dramatically increased the number of megakaryocytes in the spleen and bone marrow, indicating that TPO regulates thrombopoiesis in v~v o .~,~, ' ,~ In this report, we compare TPO from three species: pig, mouse, and human. A variant form of TPO (TPO-2) is identified in each species. TPO-2 has a four-amino-acid deletion within the epo homology domain and was unable to stimulate BaJF3-mpl proliferation. Characterization of the human gene indicates that the two splice forms of TPO arise from the use of alternative splice acceptor sites within exon 6. The human gene is localized to chromosome 3q27-28, a region of the long arm of chromosome 3, previously associated with elevated platelet counts and increased bone marrow megakaryocytes in patients with acute nonlymphocytic leukemia.""' 
MATERIALS AND METHODS
Isolation of the porcine TPO gene and cDNA. Genomic clones of the porcine TPO gene were isolated by screening a pig genomic library (EMBL3; Clontech Inc, Palo Alto, CA) with pR45, a previously described oligonucleotide probe? This probe was derived from a polymerase chain reaction (PCR) product obtained using amino acid sequence information from purified porcine "PO. Clones (2 X lo6) were lifted on nitrocellulose filters and hybridized overnight to pR45 in 35% formamide, 5X SSC, 50 mmol/L Na PO, pH 6.5, 0.1% sodium pyrophosphate, lox Denhardt's solution, 0.1% sodium dodecyl sulfate (SDS), 0.1 mg/mL salmon sperm DNA and washed for 45 minutes in 0.3X SSC, 0.1% SDS at 42°C. Several clones were isolated, and the exon corresponding to the amino acid sequence obtained from the purified porcine TPO was sequenced. The porcine TPO cDNA was obtained by rapid amplification of cDNA ends (RACE) PCR with the following modifications. Polyadenylated mRNA was isolated from the kidney of an aplastic pig, as previously de~cribed.'~ Single-strand cDNA was first prepared by reverse transcription using BamdT: 5'GACTCGAGGATCCATC-3'. An initial round of PCR amplification (28 cycles of 60 seconds at 95"C, 60 seconds at 58°C. and 90 seconds at 72°C) was conducted using the TPO-specific primer F-l (5'GCTAGCTCTAGAAATTGCTCCTCGTGGTCATGCTI'CT 3') and the shortened antisense primer BAMAD (5' GACTCGAGGAT-CCATCG 3') in a 100-pL reaction (50 mmoVL KCI, 1.5 mmoVL MgCI, 10 mmol/L Tris pH 8.0, 0.2 mmoVL dNTPs, with 0.05 U/ pL Amplitaq polymerase, Perkin Elmer Inc, Nonvalk, CT). The PCR product was digested with Cia I and ligated to 0.1 pg of Bluescript SK-vector (Stratagene Inc, La Jolla, CA), previously digested with Cia I and Kpn I. After incubation for 2 hours at room temperature, one fourth of the ligation mixture was subjected to a second round of PCR (22 cycles as described above) using the internal TPO-specific primer F-2 (5' GCTAGCTCTAGAAGC-CCGGCTCCTCCTGCCTG 3') and the T3 primer (5' CGAAA-'ITAACCCTCACTAAAG 3'). The resulting PCR product was digested with Xba I and Cia I and subcloned into Bluescript SK-. Several clones from independent PCRs were sequenced. The DNA For personal at PENN STATE UNIVERSITY on February 23, 2013. bloodjournal.hematologylibrary.org From sequence of the first seven deduced amino acids of the mature TPO were derived from sequence contained within the PCR primers.
lsolnrion ofmwine TPO (.DNA. A XgtlO cDNA library prepared from murine liver mRNA (Clontech. Inc) was screened with a prohe encompassing the entire coding region of the human TPO cDNA. Clones (2 X 10") were screened essentially as described above with a probe labeled by the random oligonucleotide method using ["PIlabeled d-adenosine triphosphate (dATP) and ("PI-labeled d-cytidine triphosphate (dCTP). cDNA from purified phage were suhcloned into the EcoRI site of Rluescript SK-(Stratagene). and the DNA sequence of both strands was determined on an AB1373 automated sequencer.
fsolrrrion ofthe l w t w n TPO g e n~. Human genomic DNA clones of the TPO gene were isolated from a human genomic library in XGem12. as previously described.'
Norfhern blot ctncrlwis. A northern blot of poly (A)' RNA from various mouse tissues (2 per lane) was purchased from Clontech and hybridized overnight with a random oligonucleotide-labeled probe containing the entire murine TPO coding region. The blot was washed at 42°C in 0.2X SSC/O.I% SDS and exposed ovcrnight to X-omat film (Kodak. Rochester. NY).
Expression qf recomhincrttr TP 0. Expression vectors for murine and human TPO were prepared as previously described.' Clones encoding TPO and TPO-2 were subcloned into pRKStkneo. a mammalian exprcssion vector containing the cytomegalovirus (CMV) promoter and thc SV40 polyadenylation signal. The resulting expression vectors (PRKtkneo-mTPO. PRKtkneo-mTPO-2. PRKtkneohTPO. and PRKtkneo-hTPO-2) were transiently transfected into 293 cells (a human embryonic kidney cell line) using the calcium phosphate method. After transient transfection. medium was conditioned for 3 days. Cells were maintained in high glucose Dulhecco's modified Eagle's medium (DMEM) supplemented with 10% fetal calf serum (FCS).
Prol;ferdorl msny.s. Stable cell lines expressing human or murine c-mpl in RalF3 cells were prepared as described previously.' RdF3 cells were maintained in RPM1 1 Comparison of the predicted mature TPO from mouse, pig, and human. The predicted amino acid sequence of murine, porcine, and human TPO (m-TPO, p-TPO, and h-TPO, respectively) are aligned. Identical amino acids are boxed, and gaps introduced for optimal alignment are indicated by dashes. Potential N-linked glycosylation sites are indicated by the shaded boxes. The conserved cysteine residues are indicated by dots. The conserved dibasic amino acid motif that presents a potential protease cleavage point is underlined. The four-amino-acid deletion found to occur in each species (TPO-2) is outlined by a box. man TPO, TPO-2, or the control plasmid pRK were transiently transfected into 293 cells by the calcium phosphate method. After 12 hours, the medium was replaced with serum-free DMEM containing 0.05 mCi/mL [3sS]-methionine and cysteine. Medium was conditioned for 4 hours. TPO was immunoprecipitated with rabbit polyclonal antisera raised against human TPO, and subjected to SDS-PAGE under reducing conditions. Chromosomal localization. Mapping of a TPO cDNA probe (1.8 kb) was performed by fluorescence in situ hybridi~ation'~ to normal human lymphocyte chromosomes counterstained with propidium iodide and 4',6-diamidino-2-phenylindole (DAPI). Biotinylated probes were detected with avidin fluorescein isothiocyanate (FITC). Images of metaphase preparations were captured by a thermoelectrically cooled charged coupled camera (Photometrics, Tucson, AZ). Separate images of DAPI banded chromosome^'^ and the hybridization signals obtained using the TPO probe were acquired and merged using image analysis software.
RESULTS
Porcine TPO cDNA was isolated by PCR using an oligonucleotide dT primer and two specific primers based on the genomic sequence of the exon of the TPO gene encoding the N-terminal amino acid sequence obtained from purified mature TPO.' The cDNA was synthesized from various tissues of aplastic pigs and amplified using a modified RACE-PCR technique. A product of 1,342 bp was obtained from kidney mRNA and subcloned. Several clones were sequenced and found to encode the complete mature pig TPO. The cDNA encodes a 332-amino-acid mature protein (Fig  1) . TPO-2, a second form, encoding a protein with a fouramino-acid deletion corresponding to amino acid residues 112 to 115, was also identified.
Murine TPO cDNAs were isolated from a mouse liver cDNA library using probes derived from the human TPO cDNA.5 The longest murine TPO cDNA clone contained an open reading frame of 1,068 bp flanked by 137 bases of 5' and 244 bases of 3' untranslated sequence followed by a poly(A) amino acids (Fig 1) . Several clones (four of eight) had a deletion of 12 bp corresponding to amino acid residues I I2 to 115 and are, therefore, analogous to the porcine TPO-2 described above. We also identified several human TPO-2 cDNA clones with a 12-bp deletion at the same position. Northern blot analysis of mRNA from various mouse tissues A exon 1 exon 2 exon 3 exon 4
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I ATG indicates the presence of a single 1.8-kb transcript in liver and kidney (Fig 2) . This result is consistent with the expression pattern observed for human TPO. Expression was found to be higher in the liver than in the kidney.
Comparison of the predicted amino acid sequences of the mature TPO from human, mouse, and pig (Fig 1) showed a 72% sequence identity between mouse and human, 68% identity between mouse and pig, and 73% identity between human and pig. The homology is substantially greater in the amino terminal half of TPO (epo homologous domain). This domain is 8 1 % to 85% identical between any two species, whereas the carboxyl half is only 57% to 67% identical. A conserved dibasic amino acid motif that could represent a protease cleavage site is present at the carboxyl end of the epo homology domain (positions 153 and 154) in all three species. A second dibasic site present at position 245 and 246 in the human sequence is not conserved in the murine and porcine sequences. The three TPO sequences contain four conserved cysteines located within the amino terminal half of the protein. There are seven potential N-linked glycosylation sites within murine TPO and six within porcine TPO. Four glycosylation sites are conserved among murine, porcine, and human TPO. All the potential N-linked glycosylation sites are located in the C-terminal half of the protein.
To determine whether the two splice forms of TPO are expressed, cells transfected with expression vectors encoding human TPO or TPO-2 were incubated in the presence of [3sS]-labeled methionine and cysteine. and conditioned medium was immunoprecipitated with a polyclonal antibody directed against human TPO. A strong, broad band of 68 to 85 kD was detected in medium from cells transfected with pRKtkneo-hTPO, whereas only a weak but detectable band was observed in medium from cells transfected with pRKtkneo-hTPO-2 (Fig 3) . Quantitation of relative expression by phosphoimager analysis indicated a 500-fold greater expression of TPO than TPO-2. To determine if the two splice forms of TPO encode functional c-mpl ligands, expression vectors containing the entire coding sequence of murine and human TPO and TPO-2 were transfected into 293 cells, and conditioned medium from transfected cells was assayed for ability to stimulate proliferation of BaE3 cells stably transfected with either murine or human c-mpl. Conditioned medium from cells transfected with murine or human TPO cDNA stimulated ['HI-thymidine incorporation in BaE3 cells expressing either receptor (Fig 4) but not in parental B e 3 cells (data not shown), indicating that the cloned mu- C t a C g a a~~g g~t c t g a g a g a a t t~a~t t g~~c~~~a~c t t a c c a t g t a~~~t t~~t g~a g c t g c t a t t c t t~~~g~t~g t   3701 g t t t g a t g t t t a g C . t C c c c a t t g t g g~~~t g c t = g t a c a g a~c t = t~t t = = g~g t g g a c t a c a c t t a~~t~t~~t m = = t g a a c~c c~a c a t c c c c c a g~a a g a g t a~~t t t~C~g c~~t~a~~c a a g a~t a a a a g c t g t~~~~~g~a g a t t t c n g c a a~t a a g a a a~a a~~g~t c t t rine and human TPO cDNAs encode functional c-mpl ligands. However, comparison of the titration curves obtained in parallel experiments using conditioned medium containing human TPO versus murine TPO shows a degree of species specificity. Conditioned medium from cells transfected with expression vectors encoding either murine or human TPO-2 did not induce a proliferative response in BalF3-mpl cells. The ability to detect TPO activity at dilutions greater than the 500-fold difference in expression between TPO and TPO-2 suggests that the limited amount of TPO-2 that is expressed is not active.
Analysis of both human and murine genomic DNA by Southern blot indicates that the gene for TPO is present in a single copy (data not shown). The human TPO gene was isolated in two overlapping lambda clones spanning 35 kb. Two overlapping fragments (BumH1 and EcoRI) containing the entire TPO gene were subcloned and sequenced. The structure of the human gene is composed of six exons within 7 kb of genomic DNA (Fig 5) . The boundaries of all exon/ intron junctions are consistent with the consensus motif established for mammalian genes." Exon 1 and exon 2 contain 5' untranslated sequence and the initial four amino acids of the signal peptide. The remainder of the secretory signal and the first 26 amino acids of the mature proteir. are encoded within exon 3. The entire carboxyl domain and 3' untranslated, as well as approximately 50 amino acids of the epolike domain, are encoded within exon 6. The four amino acids involved in the deletion observed within TPO-2 are encoded at the 5' end of exon 6.
The chromosomal location of the human WO gene was determine by fluorescent in situ hybridization (FISH). The full-length human TPO cDNA was biotinylated and hybridized to the metaphase spreads of a normal individual. The 1.8-kb cDNA gave a clear FISH signal that mapped to 3q27-28 (Fig 6) . The regional assignment was determined by the analysis of 20-well spread metaphases. A detectable hybridization signal at 3q27-28 was noted in 45 of 100 chromatid targets.
DISCUSSION
The cDNA of porcine TPO and murine TPO encode putative mature proteins of 332 amino acids and 335 amino acids, with molecular weights of 35.1 kD and 37.8 kD, respectively. TPO contains two distinct domains roughly corresponding to the amino-and carboxyl-terminal halves of the protein. The amino-terminal 153 amino acids of TPO bear homology to epo (23% identity, 50% similarity, including conservative substitutions with human TPO)? Three of the four cysteines present within epo, including the two found to be essential for epo activity," are conserved in TPO, suggesting that this domain may assume a four a-helix bundle configuration similar to other members of the hematopoietic cytokine family.Ig use only. The carboxyl domain of TPO is not present in epo or any of the other hematopoietic growth factors identified to date. Interestingly, all the potential N-linked glycosylation sites of TPO from each species are confined to the carboxyl domain of the protein. Immunoprecipitation of human TPO shows a protein of 68 to 85 kD, suggesting that this domain is highly glycosylated as the predicted molecular weight for the nonglycosylated molecule is 38 kD. The function of this highly glycosylated domain remains to be determined. Glycosylation of the carboxyl domain of TPO may provide a longer half-life for TPO in vivo, as in the case for epo.2au TPO does not display strict species specificity. Porcine TPO was purified based on its ability to bind to recombinant human mpl-IgG fusion protein and stimulate [3H]-thymidine incorporation in B e 3 cells expressing human c-mpl, and recombinant human TPO induced platelet production in a mouse rebound thrombocytosis assay. 5 Here we demonstrate that recombinant murine TPO and human TPO are able to induce a proliferative response in B e 3 cells transfected with either murine c-mpl or human c-mpl. The lack of strict species specificity is consistent with the high degree of conservation within the amino-terminal domain. There is, however, a degree of species specificity. Human and murine TPO expression in the conditioned medium of transiently transfected 293 cells was similar as estimated by immunoprecipitation using polyclonal antisera raised against the human TPO epo-like domain (data not shown). This suggests that the human ligand is less active than the murine ligand on the murine receptor.
Two alternative splice forms of TPO have been identified. They differ by the presence (TPO) or absence (TPO-2) of a four-amino-acid insertion at positions 112 to 115. The insertioddeletion occurs within the amino terminal epo-like domain at an identical position within murine, porcine, and human TPO. The four amino acids are encoded at the 5' junction of exon 6 in the human gene. The TPO-2 mRNA form may result from the use of a favorable alternative splice acceptor sequence. To date, no splice variants of epo have been identified. However, granulocyte colony-stimulating factor (G-CSF) does possess two alternative splice variants that differ by a three-amino-acid deletiodinsertion. Both of these forms are active, although the larger splice form is reported to have a lower specific a~tivity.'~ In contrast, we have not observed any agonist activity with TPO-2, the shorter form. Immunoprecipitation experiments suggest that TPO-2 is very poorly secreted. A similar deletion has been introduced into epo to study epo function.% This five-aminoacid deletion of residues 122 to 126 alters a loop between alpha helixes C and D in the proposed structure of epo and results in an inhibition of secretion. By comparison with epo, the four-amino-acid deletion within TPO-2 would also be predicted to occur within this loop. Thus, the significance of TPO-2 is uncertain. As mRNA encoding the shorter TPO form appears to be abundant in each of the three species examined to date, this may represent a novel mechanism for cytokine regulation. The level of TPO expression could potentially be modulated by altering the proportion of TPO mRNA that is spliced to encode each of the forms.
The human TPO gene was mapped by FISH to chromosome 3q27-28. Although no other cytokine gene has been localized to this locus, it will be of interest to examine this region, as there are several examples in the human and the mouse genome of close tandem linkage of genes encoding growth factors or growth factor receptors. The first to be described was a region of chromosome 5 containing the genes coding for granulocyte-macrophage (GM)-CSF, IL-3, IL-4, and IL-5.25.26 The mapping of the TPO gene is particularly interesting, as structural abnormalities of the long arm of chromosome 3 have been associated with increased bone marrow megakaryocytes and elevated platelet counts in patients with acute nonlymphocytic leukemia.1°-12 Although frequently found in combination with other chromosomal defects, the most common abnormality in these patients is an inversion of 3q between bands 21 and 26.2, suggesting that a gene critical to the regulation of thrombopoiesis may be located at one end of the inverted segment. In fact, elevated levels of TPO activity have been measured in the serum of patients with 3q inversion." Characterization of the TPO gene and of its promoter in these patients will help to determine if aberrant production of TPO is responsible for this leukemia.
